Lu, Yang MD, PhD∗; Xu, Guofan MD, PhD∗; Jimenez, Camilo MD†
From the ∗Division of Diagnostic Imaging, Department of Nuclear Medicine
†Division of Internal Medicine, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX.
Received for publication December 4, 2022; revision accepted December 30, 2022.
Conflicts of interest and sources of funding: none declared.
Correspondence to: Yang Lu, MD, PhD, Division of Diagnostic Imaging, Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Unit Number 1483, 1400 Pressler St, Houston, TX 77030. E-mail: [email protected].
